📈 stocks · CH

RO

Roche
stocks CH
Overall assessment · Trend now + news, 30 days ?
▲ Strongly bullish strong Confidence 45 % ?
News situation · 1 items / 30 D
▲ Bullish strong 45 %
5.0 Impact / 10
By source type
Release 1

1 of 1 straight from the issuer or regulator

News, 30 days
Bullish
Signal history

Both worlds over time

Technical and news signals of the last 30 days on one timeline.

Bullish ▲Bearish ▼13.10. · News signal · Impact 5/10
30 days ago today
Technical signal News signal Size = strength
News, 30 days

What is being reported about RO

Asset Snapshot

📝 Overview Generated automatically?

RO has been the subject of 1 signals across 1 articles in the last 365 days. Sentiment skews Bullish (100%).

Breakdown: 1 bullish, 0 bearish, 0 neutral. AI confidence averages 65% across all signals.

Most-cited catalysts: Acquisition of exclusive worldwide rights to an ALK7-targeting RNAi therapy (1×), Expansion of the metabolic disease therapeutic pipeline (1×). Most-cited risk factors: Clinical trial failure of the investigational RNAi candidate (1×), Regulatory hurdles in the development of ALK7-targeting therapies (1×).

Keep exploring

Related assets

Same category or comparable signal picture — each card opens the full cockpit.